Græsholt, C.; Brembu, T.; Volpe, C.; Bartosova, Z.; Serif, M.; Winge, P.; Nymark, M.
Zeaxanthin epoxidase 3 Knockout Mutants of the Model Diatom Phaeodactylum tricornutum Enable Commercial Production of the Bioactive Carotenoid Diatoxanthin. Mar. Drugs 2024, 22, 185.
https://doi.org/10.3390/md22040185
AMA Style
Græsholt C, Brembu T, Volpe C, Bartosova Z, Serif M, Winge P, Nymark M.
Zeaxanthin epoxidase 3 Knockout Mutants of the Model Diatom Phaeodactylum tricornutum Enable Commercial Production of the Bioactive Carotenoid Diatoxanthin. Marine Drugs. 2024; 22(4):185.
https://doi.org/10.3390/md22040185
Chicago/Turabian Style
Græsholt, Cecilie, Tore Brembu, Charlotte Volpe, Zdenka Bartosova, Manuel Serif, Per Winge, and Marianne Nymark.
2024. "Zeaxanthin epoxidase 3 Knockout Mutants of the Model Diatom Phaeodactylum tricornutum Enable Commercial Production of the Bioactive Carotenoid Diatoxanthin" Marine Drugs 22, no. 4: 185.
https://doi.org/10.3390/md22040185
APA Style
Græsholt, C., Brembu, T., Volpe, C., Bartosova, Z., Serif, M., Winge, P., & Nymark, M.
(2024). Zeaxanthin epoxidase 3 Knockout Mutants of the Model Diatom Phaeodactylum tricornutum Enable Commercial Production of the Bioactive Carotenoid Diatoxanthin. Marine Drugs, 22(4), 185.
https://doi.org/10.3390/md22040185